Researcher in biotechnology and immunology focused on developing next-generation vaccines. The work centers on engineering recombinant BCG (rBCG) as an advanced platform to fight infectious diseases like tuberculosis, pertussis, and pneumococcus. Key methods include using CRISPR/Cas9 to modify BCG and integrating novel adjuvants (such as LTAK63) to significantly boost innate immune responses and generate durable, protective T-cell memory.